Buspar

Recovered more than $53 million in settlements for the class.

Buspar 2018-06-12T04:25:42+00:00

Project Description

In re Buspirone Antitrust Litigation – Jason represented plaintiffs in this nationwide class action against the manufacturer of the drug Buspar for artificially inflating prices. The case settled for $535 million.

The case settled for $535 million.